Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic

Can Qian1,2, Li Gong3, Zunyuan Yang4

  • 1Sichuan Industrial Institute of Antibiotics, Chengdu, China. qiancan8838@qq.com.

Abstract

Insights

Diastolic dysfunction in spontaneous type 2 diabetes mellitus (T2DM) rhesus monkeys mirrors human conditions. This model offers insights into diabetic cardiomyopathy and potential therapeutic targets.

Area of Science:

  • Cardiology
  • Endocrinology
  • Animal Models

Background:

  • Diastolic heart failure is a severe complication of diabetes mellitus, linked to diabetic cardiomyopathy.
  • The underlying causes and effective treatments for this condition remain largely unknown.
  • Animal models are crucial for advancing understanding and developing therapies.

Purpose of the Study:

  • To investigate cardiac structure and function in spontaneous type 2 diabetes mellitus (T2DM) rhesus monkeys.
  • To establish a suitable animal model for studying diabetic cardiomyopathy and diastolic dysfunction.
  • To explore potential pathological mechanisms contributing to diabetic heart disease.

Main Methods:

  • Enrolled 25 male rhesus monkeys (15 T2DM, 10 non-diabetic).
  • Utilized echocardiography and cardiac magnetic resonance imaging (CMR) for cardiac assessment.
  • Performed pathological and protein expression studies on sacrificed animals.

Main Results:

  • Six T2DM monkeys exhibited diastolic dysfunction (DD) with characteristic echocardiographic findings (low e' velocity, altered E/A ratios).
  • CMR revealed increased left ventricular internal diameter (LVID) in DD monkeys.
  • Pathology showed myocardial lesions, mitochondrial impairment, and increased AGEs and caspase-3 expression in a DD subject.

Conclusions:

  • Spontaneous T2DM rhesus monkeys display imaging and physiological markers consistent with human diabetic cardiomyopathy and diastolic dysfunction.
  • This established monkey model is valuable for understanding disease pathology.
  • The model provides a foundation for exploring preventative and therapeutic strategies for diabetic cardiomyopathy.